Skip to main navigation

Home
Development Programs
VX15 Immuno-Oncology
VX15 Neurology
VX18 Neurology
VX15 Autoimmune
NKT Vaccine
NKT Vaccine
ActivMAb^®
Vaccinia Display
Capabilities
Optimization
Target Identification
Publications
News & Publications
- News
- Publications
Careers
Corporate
Investors
Main navigation
Events
Presentations

Home
About
Corporate Overview
Management
Partners
Pipeline
Pepinemab
Neurology
Pepinemab
Immuno-Oncology
Research & Development Programs
Clinical Trials
Patients
Physicians & Researchers
News & Publications
- News
- Publications
Investors
Main navigation
Events
Presentations
Careers
Contact Us
ActivMAb ^®

Science in the service of medicine

About
Pipeline
Clinical Trials
- Patients
- Physicians & Researchers

News & Publications
- News
- Publications
Investors
Main navigation
Events
Presentations
Careers
Contact Us
ActivMAb ^®

Event Details

Event Details

Investors

Investor Overview
News Releases
Events
Presentations
Stock Information
Corporate Governance
Financial Information
Investor Services

Shareholder Tools

Print Page
RSS Feeds
E-mail Alerts
IR Contacts
LinkedIn
Twitter

Event Details

Antibody Engineering and Therapeutics

12/04/22 - 10/08/22

Title

Antibody Engineering and Therapeutics

Date / Time

12/04/22 - 10/08/22

About
Pipeline
Clinical Trials

News
Careers
Contact

Vaccinex Inc.
1895 Mount Hope Avenue, Rochester, NY 14620
P: 585-271-2700
F: 585-271-2765
info@vaccinex.com

© 2024 Vaccinex. All rights reserved
Privacy Policy
Site by Minerva